MANVF yields 1333.33% · PFE yields 6.13%● Live data
📍 MANVF pulled ahead of the other in Year 1
Combined, MANVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MANVF + PFE for your $10,000?
Manning Ventures Inc. engages in the sourcing and exploration of mineral properties in Canada. It primarily explores for gold, silver, lead, iron ore, zinc, cobalt, uranium, rare earth, and copper deposits. The company holds interest in the Flint Lake gold project, which includes 4 separate unpatented claims covering an area of approximately 1,712 hectares located in Kenora town, northwestern Ontario. It also holds interest in the Lac Simone property, which consists of 63 mineral claims covering an area of approximately 3,287.4 hectares; and the Hope Lake property which includes 68 mineral claims covering an area of approximately 3,584.1 hectares. In addition, the has an option to acquire a 100% interest in the Broken Lake, Heart Lake, and Hydro properties that consist of 180 mineral claims covering an area of 9,501 hectares located in the Province of Quebec; and the Bounty lithium project comprises 144 mineral claims totaling 7,544 hectares. Further, it holds interest in Butterfly Pond property covering an area of 425 hectares, Mount Hogan property which covers an area of 250 hectares, Red Indian Lake property covering an area of 9,300 hectares, and Little Sheep Brook property covering an area of 700 hectares located in Newfoundland, Canada. Manning Ventures Inc. was incorporated in 2018 and is based in Vancouver, Canada.
Full MANVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.